Screening Mandates For Patients With Ctd: Improving Pah Identification

Screening Mandates for Patients with CTD: Improving PAH Identification

Understanding CTD-PAH: An Overview

The Burden of CTD-PAH: Patient Perspectives

CTD-PAH: Overview of Treatment Strategies

A Closer Look at PAH Diagnosis, Screening, and Risk Assessment

Academy for Continued Healthcare Learning

Improving outcomes in pulmonary arterial hypertension: A multidisciplinary approach

Touch Medical Media

Diagnosis and management of PAH Recommendations ESC/ERS 2022

Filière de santé FAI²R

Classification, Workup, and Treatment of Pulmonary Arterial Hypertension

ClevelandClinicCME

Pulmonary Arterial Hypertension (PAH): How to Develop an Effective Risk Reduction Strategy

The France Foundation

Pulmonary Arterial Hypertension Diagnosis, Classifications and Therapy

ClevelandClinicCME

Immunosuppression in the treatment of CTD-PAH

Vera Moulton Wall Center for Pulmonary Vascular Disease at Stanford

CTD-PAH: Adjusting Treatment Based on Patient Factors

2013 Atlanta - Grand Lecture: Pulmonary Arterial Hypertension - Dr. Dinesh Khanna

National Scleroderma Foundation

Talking PAH: Novel Therapies for Pulmonary Arterial Hypertension

Practice Point Communications

Treatment of Pulmonary Hypertension

Harvard Medical School Continuing Education

Pulmonary Arterial Hypertension: You gotta have heart

Pulmonary Arterial Hypertension (PAH): Therapy Options Explained

The France Foundation

Diagnosis of Pulmonary Hypertension

Harvard Medical School Continuing Education

PAH Treatment Goals

The Effect of Delayed Diagnosis of PAH and Identifying Patients Earlier